This prestigious award highlights an outstanding individual who has made a significant impact in the reagent sector.

We’re thrilled to announce that Dr Alejandra Solache, Senior Vice President of Research and Development for Abcam, has been named winner of the CiteAb Award for Significant Individual Impact 2021.

Dr Solache’s career in research and development has spanned industry and academia, and has demonstrated her dedication, leadership and immense contribution to the life science reagent industry.

A great deal of Dr Solache’s career has been dedicated to raising the quality and performance of researc antibodies, both within her own company and across the sector. Dr Solache champions a cooperative effort between all parties involved, including suppliers, researchers, publishers, and grant-awarding bodies, to promote the importance of reagent quality and empower researchers to make informed choices.

Dr Andrew Chalmers, founder of CiteAb, said: ““I wish to offer my personal congratulations to Dr Alejandra Solache on winning the CiteAb Award for Significant Individual Impact. Anyone who has met her will understand why she has won this award, she has such drive and passion for improving research antibody quality, and has championed the use of recombinant antibodies and improved validation across the sector. Her efforts have helped to ensure antibodies are fit to support biomedical research and ultimately the patients receiving treatment. I wish her continued success in her mission as she takes up her new role as a SVP of Research and Development at Abcam.”